This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Crescendo Bioscience. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Scott Eastman in Juvenile Idiopathic Arthritis
Introduction
Scott Eastman is an innovative inventor based in South San Francisco, California. With a focus on biomedical research, he has made significant contributions to the medical field, particularly in understanding and monitoring juvenile idiopathic arthritis (JIA). His work aims to enhance the assessment of inflammatory diseases, a vital area of research for improving patient outcomes.
Latest Patents
Scott Eastman holds a notable patent titled "Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity." This invention provides essential biomarkers that are useful for assessing inflammatory disease or flare activity in juvenile idiopathic arthritis. The patent also encompasses kits designed for measuring the expression of these biomarkers. Furthermore, it offers predictive models based on the biomarkers, alongside computer systems and software embodiments that facilitate the scoring and optional classification of samples. This innovation showcases Eastman's dedication to advancing medical diagnostics in pediatric inflammatory disorders.
Career Highlights
Scott is associated with Crescendo Bioscience, a company renowned for its efforts in providing advanced diagnostics for autoimmune diseases. His role involves leveraging his expertise in biomarker discovery and validation to develop tools that aid healthcare professionals in making informed decisions regarding treatment options for patients with JIA.
Collaborations
During his tenure at Crescendo Bioscience, Scott has collaborated with esteemed colleague Eric Sasso. Their combined efforts have contributed to the advancement of research in the field of biomarkers for various inflammatory diseases, fostering innovation that can significantly impact patient care.
Conclusion
Scott Eastman's work demonstrates the potential for innovation in the medical field, particularly through his patent for monitoring juvenile idiopathic arthritis. His contributions not only pave the way for improved diagnostic tools but also enhance the understanding and management of pediatric inflammatory diseases. The ongoing research and collaborations at Crescendo Bioscience continue to inspire advancements that hold great promise for patients globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile